Marshall Wace
EDVA

Marshall Wace’s Endovia Health Sciences, Inc. EDVA Stock Holding History

Marshall Wace’s Portfolio EDVA Stock Details EDVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-96
Closed -$21K – 3362
2022
Q3 		$21K Buy
+96
New +$36.4K ﹤0.01% 3260
2022
Q2 		– Sell
-319
Closed -$144K – 3795
2022
Q1 		$144K Buy
+319
New +$163K ﹤0.01% 3148

Other funds holding EDVA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
PCM
Parsons Capital Management Providence, Rhode Island $2.21B AUM 28.12% 1-Year Est. Return

Marshall Wace's EDVA Position: Q4 2022 in Review

Marshall Wace sold out of Endovia Health Sciences, Inc. (EDVA) in Q4 2022, closing a stake of 96 shares — an estimated $21K sold.

Marshall Wace first reported a position in EDVA in Q1 2022 and held it in 2 quarters. The position peaked at $144K in Q1 2022. 22 funds tracked by Wall St. Rank hold EDVA as of Q4 2022.

  • Marshall Wace reported no remaining Endovia Health Sciences, Inc. position as of Q4 2022 after selling out during the quarter.
  • Marshall Wace sold 96 Endovia Health Sciences, Inc. shares in Q4 2022, an estimated $21K.
  • Marshall Wace first reported a position in Endovia Health Sciences, Inc. in Q1 2022 and held it in 2 quarters.
  • Marshall Wace's Endovia Health Sciences, Inc. position peaked at $144K in Q1 2022.
  • 22 funds tracked by Wall St. Rank held Endovia Health Sciences, Inc. as of Q4 2022.

Based on Marshall Wace's 13F filing for Q4 2022, filed 14 Feb 2023.